Behavioural and sleep issues after initiation of elexacaftor–tezacaftor–ivacaftor in preschool-age children with cystic fibrosis
2024 · The Lancet · 18 citations
https://doi.org/10.1016/s0140-6736(24)01134-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
217
Citations
4
h-index
3
i10-index
Marie-Laure Dalphin is an academic researcher from CHU Dijon Bourgogne. The author has contributed to research in topics: Cystic Fibrosis Research Advances & Asthma and respiratory diseases & Neonatal Respiratory Health Research. The author has an h-index of 4, co-authored 6 publications.
https://doi.org/10.1016/s0140-6736(24)01134-6
https://doi.org/10.1016/s2213-2600(25)00190-0
https://doi.org/10.1038/s41598-024-77253-5
Click to start Chat